Skip to main content
logo
Satellos Bioscience Inc. (MSLE)
NASDAQ: MSLE · Real-Time Price · USD
9.79
+0.04 (0.41%)
Sep 14, 2026, 4:00 PM EDT - Market closed

Satellos Bioscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-34.61-24.87-20.63-12.03-8.37-12.25
Depreciation & Amortization
0.0100.020.010.250.13
Asset Writedown & Restructuring Costs
--2.91-2.13-
Loss (Gain) From Sale of Investments
-----0.03-
Stock-Based Compensation
3.413.241.641.641.060.77
Other Operating Activities
0.1-0.48-1.431.330.057.76
Change in Accounts Receivable
-----0.03
Change in Accounts Payable
3.070.51.010.60.54-0.31
Change in Other Net Operating Assets
-1.03-1.98-1.77-0.320.2-0.11
Operating Cash Flow
-29-23.6-18.25-8.77-4.17-3.98
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.01-0-0.01-0-0.01
Cash Acquisitions
-----1.38
Investment in Securities
-54.56-9.414.66-13.27--
Investing Cash Flow
-54.57-9.424.66-13.28-01.37

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---1.81--
Long-Term Debt Issued
-----0.15
Total Debt Issued
---1.81-0.15
Short-Term Debt Repaid
----1.99--
Total Debt Repaid
----1.99--
Net Debt Issued (Repaid)
----0.18-0.15
Issuance of Common Stock
48.142.2430.6626.621.475.74
Other Financing Activities
4.65-6.9211.740.58-
Financing Cash Flow
52.792.2437.5738.192.055.89

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.040.5-0.59-0.88-0.06-0
Net Cash Flow
-30.82-30.2723.3915.25-2.183.28

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-29.01-23.6-18.26-8.79-4.17-3.98
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.67-1.62-1.91-1.22-1.40-1.99
Levered Free Cash Flow
-16.92-14.76-11.72-5.49-1.85-0.13
Unlevered Free Cash Flow
-16.92-14.76-11.72-5.41-1.85-0.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
2.1-1.48-0.750.280.73-0.38
SEC Filings: 10-K · 10-Q